human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
- |
Hirschsprung disease |
ZNF609 |
hsa-miR-150-5p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
- |
duchenne muscular dystrophy |
ZNF609 |
- |
Q
S
| |
More |
human |
hsa_circ_ZNF609 |
- |
- |
vascular disease |
ZNF609 |
hsa-miR-615-5p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
- |
diabetic retinopathy |
ZNF609 |
- |
Q
M
| |
More |
human |
hsa_circ_ZNF609 |
- |
circular RNA-ZNF609 |
retinal degeneration |
ZNF609 |
hsa-miR-615 |
Q
S
| |
More |
human |
hsa_circ_ZNF609 |
- |
- |
breast cancer |
ZNF609 |
hsa-miR-145-5p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
circ-ZNF609 |
renal carcinoma |
ZNF609 |
hsa-miR-138-5p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
- |
colorectal cancer |
ZNF609 |
hsa-miR-150 |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
circ-ZNF609 |
rhabdomyosarcoma |
ZNF609 |
- |
Q
S
| |
More |
human |
hsa_circ_ZNF609 |
- |
circ-ZNF609 |
nasopharynx carcinoma |
ZNF609 |
hsa-miR-150-5p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
cZNF609 |
lymphangitis |
ZNF609 |
- |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
- |
prostate cancer |
ZNF609 |
hsa-miR-186-5p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
- |
colorectal cancer |
ZNF609 |
- |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
- |
brain glioma |
ZNF609 |
hsa-miR-134-5p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
circ-ZNF609 |
stomach cancer |
ZNF609 |
hsa-miR-145-5p |
Q
| |
More |
rat |
rno_circ_ZNF609 |
- |
- |
corneal neovascularization |
ZNF609 |
rno-miR-184 |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
- |
nasopharynx carcinoma |
ZNF609 |
hsa-miR-188 |
Q
| |
More |
human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
- |
lung cancer |
ZNF609 |
hsa-miR-1224-3p |
Q
S
| |
More |
human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
- |
nasopharynx carcinoma |
ZNF609 |
hsa-miR-338-3p |
Q
| |
More |
mouse |
mmu_circ_ZNF609 |
- |
- |
focal segmental glomerulosclerosis |
ZNF609 |
mmu-miR-615-5p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
- |
hepatocellular carcinoma |
ZNF609 |
hsa-miR-342-3p |
Q
| |
More |
mouse |
mmu_circ_ZNF609 |
- |
- |
brain disease |
ZNF609 |
mmu-miR-22-3p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
- |
prostate cancer |
ZNF609 |
hsa-miR-501-3p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
- |
nasopharynx carcinoma |
ZNF609 |
hsa-miR-338-3p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
circ-ZNF609 |
colorectal cancer |
ZNF609 |
- |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
- |
lung cancer |
ZNF609 |
hsa-miR-142-3p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
CircRNA ZNF609 |
lung non-small cell carcinoma |
ZNF609 |
hsa-miR-623 |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
- |
cervical cancer |
ZNF609 |
hsa-miR-197-3p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
CircRNA ZNF609 |
nasopharynx carcinoma |
ZNF609 |
hsa-miR-145 |
Q
| |
More |
human |
- |
hsa_circ_0000615 |
circ_0000615 |
diabetic retinopathy |
ZNF609 |
hsa-miR-646 |
Q
| |
More |
human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
- |
breast cancer |
ZNF609 |
- |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
circ-ZNF609 |
cholangiocarcinoma |
ZNF609 |
hsa-miR-432-5p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
circ-ZNF609 |
thyroid gland cancer |
ZNF609 |
hsa-miR-514a-5p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
CircZNF609 |
laryngeal squamous cell carcinoma |
ZNF609 |
hsa-miR-134-5p |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
circZNF609 |
diffuse large B-cell lymphoma |
ZNF609 |
hsa-miR-153 |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
circZNF609 |
melanoma |
ZNF609 |
- |
Q
| |
More |
human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
CircZNF609 |
urinary bladder cancer |
ZNF609 |
hsa-miR-1200 |
Q
| |
More |
human |
hsa_circ_ZNF609 |
- |
circZNF609 |
myocardial infarction |
ZNF609 |
- |
S
| |
More |
human |
hsa_circ_ZNF609 |
- |
circ-ZNF609 |
acute kidney failure |
ZNF609 |
- |
Q
| |
More |
human |
hsa_circ_ZNF609 |
hsa_circ_0000615 |
circ_0000615 |
hepatocellular carcinoma |
ZNF609 |
- |
Q
| |
More |